Venezuela exposure profile · VRTX ·
Health Care
Vertex Pharmaceuticals (VRTX): Venezuela Exposure Check
Independent audit of Vertex Pharmaceuticals's exposure to Venezuela — OFAC SDN matches, SEC filings, and Caracas Research news corpus.
OFAC Venezuela SDN matches
No entry on the OFAC Venezuela SDN list contains
Vertex Pharmaceuticals
as of the most recent OFAC scrape. Always re-verify with
OFAC Sanctions Search
before transacting.
SEC filings disclosing Venezuela items
We searched Vertex Pharmaceuticals's SEC filings (10-K,
10-Q, 8-K, 20-F, 6-K) for the past two years and found no
mention of Venezuela, PdVSA, CITGO, or Caracas. This is
consistent with no material disclosed exposure. The full SEC
full-text search is here:
EDGAR full-text search for Vertex Pharmaceuticals
.
Federal Register & news corpus mentions
No Federal Register notice or analyzed news article in our
corpus references Vertex Pharmaceuticals in a
Venezuela context. Search the live
sanctions tracker
or the
daily briefing index
for ad-hoc context.
Methodology.
This page combines four signals: (1) a hand-curated map of S&P 500
Venezuela exposure maintained by Caracas Research analysts;
(2) fuzzy substring matching against every Venezuela-program OFAC SDN
designation (refreshed twice daily); (3) the SEC EDGAR full-text search
across the company's 10-K, 10-Q, 8-K, 20-F, and 6-K filings for the
past 24 months; (4) a scan of our own analyzed-news corpus and US
Federal Register notices. Last refreshed
2026-04-19. This is not legal or compliance advice;
always verify with primary sources and qualified sanctions counsel
before transacting.